In order to determine the feasibility of this approach for the therapy of ovarian cancer in a human patient, both RT-PCR and ISH analyses were applied on cells isolated from OCAF to determine the level of H19 gene expression. The gene discussed is H19; the disease is ovarian carcinoma.